Delivery Order SPE2DB20D9127-SPE2DB25FPPS5

Award Date 1/28/25
Potential Completion Date 2/19/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,751.61 and has an ultimate completion date of December 30, 2024. The contract is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,203.86, is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. The contract has an ultimate completion date of July 3, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,751.61 contract provides the DLA with the KYLEENA 19.5 MG SYSTEMS pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a type of pharmaceutical product, with an ultimate completion date of April 16, 2024, and a ceiling value of $15,048.00. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,203.86 contract is for the delivery of 4566759551 - KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product, with a completion date of January 2, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $2,873.50 and covers the delivery of 4565361226 KYLEENA 19.5 MG SYSTEMS. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,203.86 contract is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS, and has an ultimate completion date of August 1, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,611.58, is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. The contract has an ultimate completion date of May 30, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,478.76, is for the delivery of 4567552655 KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, with a period of performance through March 28, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,174.18, is for the delivery of 4566796532 KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPPS5
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,098.45, is for the delivery of 4567323176 KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This contract is not associated with any set-aside designation.

Generated 5/22/25, 8:30 PM